Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Y BastionB Coiffier

Abstract

To assess the incidence of lymphoma transformation in the natural history of follicular lymphoma (FL) patients and the factors that are predictive of this event. Two hundred twenty patients with FL treated in our institution between 1975 and 1990, with a median follow-up duration of 9 years, were included in this retrospective analysis. Transformation was proven by histology in 34 patients or by cytology in 13 patients and was considered as highly probable on clinical arguments in five patients for an overall incidence of 24%. The probability of transformation was 22% at 5 years and 31% at 10 years and tended to plateau after 6 years. Predictive factors for transformation were nonachievement of complete remission (CR) after initial therapy (P < 10(-4), low serum albumin level (< 35 g/L) (P = .001), and beta 2-microglobulin level greater than 3 mg/L (P = .02) at diagnosis. In a multiparametric analysis, only beta 2-microglobulin level retained prognostic significance for freedom-from-transformation (FFT) survival (P = .04). Transformation accounted for 44% of deaths and was associated with a poor outcome, with a median survival time of 7 months. Transformation is an early event in the course of the disease and is mainly observed...Continue Reading

Citations

Mar 8, 2000·American Journal of Clinical Pathology·S H KroftC W Ross
Apr 11, 2000·The American Journal of Surgical Pathology·Y NatkunamP J Cornbleet
Apr 25, 2001·Histopathology·H K Müller-HermelinkG Ott
Oct 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KaminskiJ M Vose
Aug 16, 2002·Bone Marrow Transplantation·B BolwellB Pohlman
Apr 15, 2003·Bone Marrow Transplantation·R E Lerner, L J Burns
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heiko SchöderHenry W D Yeung
Feb 6, 2007·British Journal of Haematology·Andrew J DaviesT Andrew Lister
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Archana M AgarwalMegan S Lim
Oct 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Abdulwahab J Al-TourahJoseph M Connors
Aug 29, 2009·PharmacoEconomics·Talia FosterMason W Russell
Dec 16, 2011·Cancer Science·Hisaharu ShikataMasaki Yasukawa
Nov 2, 2014·Blood Cancer Journal·Y W AsmannA J Novak
Jun 20, 2014·Journal of Clinical and Experimental Hematopathology : JCEH·Koji Izutsu
Apr 29, 2015·Current Oncology Reports·Chan Yoon Cheah, John F Seymour
Oct 19, 2017·Annals of Hematology·Thais FischerStefano Luminari
Oct 20, 2017·International Journal of Cancer. Journal International Du Cancer·Jeff HosryHarrys A Torres
Mar 31, 2018·Hematological Oncology·Carla MinoiaAnnarita Conconi
Feb 13, 2003·British Journal of Haematology·Douglas E HorsmanRandy D Gascoyne
Apr 26, 2003·American Journal of Clinical Oncology·David M Mintzer, Bernard A Mason
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J DaviesJ A Radford
Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I FisherMorton Coleman
Dec 17, 2003·British Journal of Haematology·Sophie Camilleri-BroëtCatherine Sautès-Fridman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Abdulwahab J Al-TourahJoseph M Connors
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Yan ChenHui Chen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Silvia MontotoT Andrew Lister
© 2021 Meta ULC. All rights reserved